Sysmex Adjusts Deferred Tax Assets in Non-Consolidated Results

Sysmex ( (JP:6869) ) has issued an announcement.

Sysmex Corporation has announced a reversal of deferred tax assets in its non-consolidated financial results for the fiscal year ending March 31, 2025. This adjustment, amounting to ¥10,983 million, reflects a reassessment of the recoverability of these assets considering the future business environment. Importantly, this reversal does not impact the company’s consolidated financial results, which adhere to International Financial Reporting Standards (IFRS), thus maintaining stability in its overall financial positioning.

The most recent analyst rating on (JP:6869) stock is a Buy with a Yen3500.00 price target. To see the full list of analyst forecasts on Sysmex stock, see the JP:6869 Stock Forecast page.

More about Sysmex

Sysmex Corporation operates in the healthcare industry, primarily focusing on the development and manufacturing of diagnostic and testing instruments and reagents. The company is known for its contributions to hematology and other laboratory testing solutions, serving a global market with innovative healthcare technologies.

Average Trading Volume: 1,229,012

Technical Sentiment Signal: Sell

Current Market Cap: Yen1646.3B

Learn more about 6869 stock on TipRanks’ Stock Analysis page.